Generation of major histocompatibility complex class I antigens

Microbes and Infection

Volumn 5, Issue 1, 2003, Pages 39-47

  Yang, Young ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Immune; MHC; PA28; Proteasome; TAP

Indexed keywords

ADENOSINE TRIPHOSPHATASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME; PROTEIN PA28; REGULATOR PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGENICITY; BIOSYNTHESIS; CELL FUNCTION; CELL SURFACE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; INFECTION; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RIBOSOME; VIRUS INTERFERENCE; WART VIRUS;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CYSTEINE ENDOPEPTIDASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MULTIENZYME COMPLEXES; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRUSES;

EID: 0037273382     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00050-3     Document Type: Review

References (50)

1. Paul W.E. Fundamental Immunology. 1993;Raven Press, New York.
2. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:1996;369-396.
3. Yewdell J.W. Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol. 11:2001;294-297.
4. Ting J.P., Baldwin A.S. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:1993;8-16.
5. Hwang L.Y., Lieu P.T., Peterson P.A., Yang Y. Functional regulation of immunoproteasomes and transporter associated with antigen processing. Immunol. Res. 24:2001;245-272.
6. Glas R., Bogyo M., McMaster J.S., Gaczynska M., Ploegh H.L. A proteolytic system that compensates for loss of proteasome function. Nature. 392:1998;618-622.
7. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-848.
8. Cresswell P., Bangia N., Dick T., Diedrich G. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172:1999;21-28.
9. Ortmann B., Copeman J., Lehner P.J., Sadasivan B., Herberg J.A., Grandea A.G., Riddell S.R., Tampe R., Spies T., Trowsdale J., Cresswell P. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science. 277:1997;1306-1309.
10. Garcia K.C., Teyton L., Wilson I.A. Structural basis of T cell recognition. Annu. Rev. Immunol. 17:1999;369-397.
11. Wang J.H., Reinherz E.L. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol. Immunol. 38:2002;1039-1049.
12. Beck S., Trowsdale J. The human major histocompatibility complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 1:2000;117-137.
13. Fremont D.H., Matsumura M., Stura E.A., Peterson P.A., Wilson I.A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 257:1992;919-927.
14. Brouwenstijn N., Serwold T., Shastri N. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity. 15:2001;95-104.
15. Serwold T., Gaw S., Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2:2001;644-651.
16. Lauvau G., Kakimi K., Niedermann G., Ostankovitch M., Yotnda P., Firat H., Chisari F.V., van Endert P.M. Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells. J. Exp. M. 190:1999;1227-1240.
17. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 404:2000;770-774.
18. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18:2000;861-926.
19. Brooks P., Murray R.Z., Mason G.G.F., Hendil K.B., Rivett A.J. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352:2000;611-615.
20. Harris J.L., Alper P.B., Li J., Rechsteiner M., Backes B.J. Substrate specificity of the human proteasome. Chem. Biol. 8:2001;1131-1141.
21. Toes R.E.M., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P.N., Kraft M., Laplace C., Zwinderman A., Dick T.P., Muller J., Schonfisch B., Schmid C., Fehling H.J., Stevanovic S., Rammensee H.G., Schild H. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. M. 194:2001;1-12.
22. Khan S., Van den Broek M., Schwarz K., De Giuli R., Diener P.A., Groettrup M. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167:2001;6859-6868.
23. Tamura N., Lottspeich F., Baumeister W., Tamura T. The role of tricorn protease and its aminopeptidase-interacting factors in cellular protein degradation. Cell. 95:1998;637-648.
24. Serwold T., Gonzalez F., Kim J., Jacob R., Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 419:2002;480-483.
25. Stoltze L., Schirle M., Schwarz G., Schroter C., Thompson M.W., Hersh L.B., Kalbacher H., Stevanovic S., Rammensee H.G., Schild H. Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1:2000;413-418.
26. Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K., Niedermann G. A giant protease with potential to substitute for some functions of the proteasome. Science. 283:1999;978-981.
27. Menoret A., Li Z., Niswonger M.L., Altmeyer A., Srivastava P.K. An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility of class I is an aminopeptidase. J. Biol. Chem. 276:2001;33313-33318.
28. Reed R.C., Zheng T., Nicchitta C.V. GRP94-associated enzymatic activities. J. Biol. Chem. 277:2002;25082-25089.
29. Beninga J., Rock K.L., Goldberg A.L. Interferon-γ can stimulate post-proteasomal trimming of the N-terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273:1998;18734-18742.
30. Zaiss D.M.W., Standera S., Kloetzel P.M., Sijts A.J.A.M. PI31 is a modulator of proteasome formation and antigen processing. Proc. Natl. Acad. Sci. USA. 99:2002;14344-14349.
31. Ustrell V., Hoffman L., Pratt G., Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21:2002;3516-3525.
32. Kleijnen M.F., Shih A.H., Zhou P., Kumar S., Soccio R.E., Kedersha N.L., Gill G., Howley P.M. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell. 6:2000;409-419.
33. Fruh K., Yang Y. Antigen presentation by MHC class I and its regulation by interferon γ Curr. Opin. Immunol. 11:1999;76-81.
34. Preckel T., Fung-Leung W.P., Cai Z., Vitiello A., Salter-Cid L., Winqvist O., Wolfe T.G., Herrath M.V., Angulo A., Ghazal P., Lee J.D., Fourie A.M., Wu Y., Pang J., Ngo K., Peterson P.A., Fruh K., Yang Y. Impaired immunoproteasome assembly and immune responses in PA28 - / - mice. Science. 286:1999;2162-2165.
35. Whitby F.G., Masters E.I., Kramer L., Knowlton J.R., Yao Y., Wang C.C., Hill C.P. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature. 408:2000;115-120.
36. McMichael A.J., Rowland-Jones S.L. Cellular immune responses to HIV. Nature. 410:2001;980-987.
37. Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., De Carli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407-410.
38. Klenerman P., Rowland-Jones S., McAdam S., Edwards J., Daenke S., Lalloo D., Koppe B., Rosenberg W., Boyd D., Edwards A. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:1994;403-407.
39. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., Masucci M.G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA. 94:1997;12616-12621.
40. Gilbert M.J., Riddell S.R., Li C.R., Greenberg P.D. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:1993;3461-3469.
41. Shamu C.E., Flierman D., Ploegh H.L., Rapoport T.A., Chau V. Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mol. Biol. Cell. 12:2001;2546-2555.
42. Wiertz E.J.H.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
43. Hu Z., Zhang Z., Doo E., Coux O., Goldberg A.L., Liang T.J. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73:1999;7231-7240.
44. Ohana B., Moore P.A., Ruben S.M., Southgate C.D., Green M.R., Rosen C.A. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc. Natl. Acad. Sci. USA. 90:1993;138-142.
45. Berezutskaya E., Bagchi S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J. Biol. Chem. 272:1997;30135-30140.
46. Rousset R., Desbois C., Bantignies F., Jalinot P. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature. 381:1996;328-331.
47. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science. 290:2000;2155-2159.
48. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555.
49. Lelouard H., Gatti E., Cappello F., Gresser O., Camosseto V., Pierre P. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature. 417:2002;177-182.
50. Garcia K.C., Degano M., Stanfield R.L., Brunmark A., Jackson M.R., Peterson P.A., Teyton L., Wilson I.A. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.